Erratum: Folate and methionine metabolism in autism: a systematic review (The American Journal of Clinical Nutrition (2010) 91(6) (1598–1620), (S0002916523017409), (10.3945/ajcn.2009.29002));Folate and methionine metabolism in autism: A systematic review

American Journal of Clinical Nutrition

Volumn 91, Issue 6, 2010, Pages 1598-1620

  Main, Penelope A E ^a,b   Angley, Manya T ^a   Thomas, Philip ^b   O'Doherty, Catherine E ^a   Fenech, Michael ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHIONINE;

CENTRAL NERVOUS SYSTEM; DIET SUPPLEMENTATION; FOLIC ACID BLOOD LEVEL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; INFANTILE AUTISM; METABOLISM; NUTRIENT UPTAKE; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SULFATION AND DESULFURIZATION; SYSTEMATIC REVIEW;

EID: 77953033904     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2010.30167     Document Type: Erratum

References (52)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: text revision (DSM-IV-R). Washington, DC: American Psychiatric Association, 2000.
2. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 2003;33:365-382 (Pubitemid 37127933)
3. Autism Genome Project Consortium, Szatmari P, Paterson AD, et al. Mapping autism risk loci using genetic linkage and chormosomal rearrangments. Nat Genet 2007;39:319-328
4. Morrow EM, Yoo S-Y, Flavell SW, et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008;321:218-223
5. Christian SL, Bune CW, Sudi J, et al. Novel submicroscopic abnormalities detected in autism spectrum disorder. Biol Psychiatry 2008;63: 1111-1117
6. Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 2007;17:103-111 (Pubitemid 46237744)
7. Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet 2006;368:2167-2177
8. Kern JK, Jones AM. Evidence of toxicity, oxidative stress and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006;9:485-499
9. Slotkin TA, Vevin ED, Seidler FJ. Comparative developmental neurotoxicity of organophsphate insecticides: effects on brain development are separable from systemic toxicity. Environ Health Perspect 2006;114: 746-751
10. van den Pol AN. Viral infections in the developing and mature brain. Trends Neurosci 2006;29:398-406.
11. Horvath K, Perman J. Autistic disorder and gastrointestinal disease. Curr Opin Pediatr 2002;14:583-587
12. White JF. Intestinal pathophysiology in autism. Exp Biol Med (Maywood) 2003;228:639-649
13. Das SK, Kunkel TA, Loeb LA. Effects of altered nucleotide concentrations on the fidelity of DNA replication. Basic Life Sci 1985;31:117-126
14. Selhub J, Rosenberg IH. Folic acid. In: Ziegler EE, Filer LJ Jr, eds. Present knowledge in nutrition. 7th ed. Washington, DC: International Life Sciences Institute Press, 1996:206-219
15. Barbato JC, Catanescu O, Murray K, DiBello PM, Jacobsen DW. Targeting of metallothioneine by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis. Arterioscler Thromb Vasc Biol 2007;27:49-54.
16. Fang YZ, Yang S, Wu G. Free radicals, antioxidants and nutrition. Nutrition 2002;18:872-879
17. Schafer FQ, Beuttner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191-1212
18. Petrozzi L, Lucetti C, Scarpato R, et al. Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients. Neurol Sci 2002;23(suppl):S97-8.
19. Thomas P, Hecker J, Faunt J, Fenech M. Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease. Mutagenesis 2007;22:371-379 (Pubitemid 350098492)
20. Thomas P, Harvey S, Gruner T, Fenech M. The buccal cytome and micronucleus frequency is substantially altered in Down's syndrome and normal ageing compared to young healthy controls. Mutat Res 2008; 638:37-47.
21. Psimadas D, Messini-Nikolaki N, Zafiropoulou M, Fortos A, Tsilimigaki S, Piperakis SM. DNA damage and repair efficiency in lymphocytes from schizophrenic patients. Cancer Lett 2004;204:33-40. (Pubitemid 38117191)
22. Muntjewerff JW, Van der Put N, Eskes T, et al. Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia. Psychiatry Res 2003;121:1-9. (Pubitemid 37311383)
23. Chou YF, Yu C, Huan RS. Changes in mitochondrial DNA deletion, content, and biogenesis in folate-deficient tissues of young rats depend on mitochondrial folate and oxidative DNA injuries. J Nutr 2007;137: 2036-2042 (Pubitemid 47367262)
24. Chou YF, Huang RS. Mitochondrial DNA deletions of blood lymphocytes as genetic markers of low folate-related mitochondrial genotoxicity in peripheral tissues. Eur J Nutr 2009;48:429-436
25. Djukic A. Folate-responsive neurologic diseases. Pediatr Neurol 2007; 37:387-397
26. Schopler E, Reichler R, Renner B. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord 1980;10:91-103. (Pubitemid 10050041)
27. National Health and Medical Research Council. A guide to the development, implementation and evaluation of clinical practice guidelines. Canberra, Australia: Australian Governement Publishing Service, 1999.
28. James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004;80:1611-1617 (Pubitemid 41103861)
29. James SJ, Melnyk S, Jernigan S, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006;141:947-956
30. Suh JH, Walsh, WJ, McGinnis WR, Lewis A, Ames BN. Altered sulfur amino acid metabolism in immune cells of children diagnosed with autism. Am J Biochem Biotech 2008;4:105-113 (Pubitemid 351573645)
31. Khaleeluddin K, Philpott WH. I. The clinical report of ecologic and nutritional disorders in chronic mental and physical degenerative diseases. II. The significance of B6 and methionine metabolic disorders in mental disease. J Appl Nutr 1980;32:37-52. (Pubitemid 11166179)
32. Visconti P, Piazzi S, Posar A, Santi A, Pipitone E, Rossi PG. Amino acids and infantile autism. Dev Brain Dysfunct 1994;7:86-92.
33. D'Eufemia P, Finochhiaro R, Celli M, Viozzi L, Monteleone D, Fiardini O. Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism. Biomed Pharmacother 1995;49:288-292
34. Arnold GL, Hyman SL, Mooney RA, Kirby RS. Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J Autism Dev Disord 2003;33:449-454
35. Moretti P, Sahoo T, Hyland K, et al. Cerebral folate deficiency with developmental delay, autism and response to folinic acid. Neurology 2005;64:1088-1090
36. Adams M, Lucock M, Stuart J, Fardell S, Baker K, Ng X. Preliminary evidence for involvement of the folate gene polymorphism 19-bp deletion-DHFR in occurrence of autism. Neurosci Lett 2007;422:24-29
37. Pasca S, Nemes B, Vlase L, et al. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 2006;78:2244-2248
38. Moretti P, Peters SU, del Gaudio D, et al. Brief report: autistic symptoms, developmental regression, metal retardation, epilepsy and dyskinesias in CNS folate deficiency. J Autism Dev Disord 2008;38:1170-1177
39. Siva Sankar DV. Plasma levels of folates, riboflavin, vitamin B6 and ascorbate in severely disturbed children. J Autism Dev Disord 1979;9:73-82.
40. Lowe TL, Cohen DJ, Miller S, Young JG. Folic acid and B12 in autism and neuropsychiatric disturbances of childhood. J Am Acad Child Adolesc Psychiatry 1981;20:104-111
41. Adams JB, Holloway C. Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J Alt Complement Med 2004;10: 1033-1039 (Published erratum appears in J Alt Complement Med 2004;11.)
42. Ramaekers VT, Rothenberg S, Sequeira JM, et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 2005;352:1985-1990
43. Adams JB, George F, Audhya T. Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements compared to controls not taking supplements. J Altern Complement Med 2006;12: 59-63. (Pubitemid 43346324)
44. Ramaekers VT, Blau N, Sequeria JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological defects. Neuropediatrics 2007; 38:276-281 (Pubitemid 351737986)
45. Boris M, Goldblatt A, Goalanko J, James SJ. Association of MTHFR gene variants with autism. J Am Phys Surg 2004;9:106-108
46. Bolander-Gouaille C, Bottiglieri R. Homocysteine: related vitamins and neuropsychiatric disorders. 2nd ed. Paris, France: Springer-Verlag, 2007.
47. Angley M, Semple S, Hewton C, Paterson F, McKinnon R. Children and autism: Part 2 - management with complementary medicines and dietary interventions. Aust Fam Physician 2007;36:827-830
48. Gerster H. The importance of vitamin B6 for development of the infant: human medical and animal experimental studies. Z Ernahrungswiss 1996;35:309-317 (in German). (Pubitemid 27006971)
49. Kimura M, Umegaki K, Higuchi M, Thomas P, Fenech M. Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J Nutr 2004;134:48-56. (Pubitemid 38057422)
50. Coppedè F, Colognato R, Bonelli A, et al. Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down Syndrome children. Am J Med Genet A 2006;143A:2006-2015 (Pubitemid 47344262)
51. Iarmarcovai B, Bonassi S, Botta A, Baan RA, Orsie're T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res 2008;658:215-233
52. Rothenberg SP, Da Costa MP, Sequeira JM, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med 2004;350:134-142